571 related articles for article (PubMed ID: 30403144)
1. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies.
Shah R; Brodsky SV; Hebert L; Rovin BH; Nadasdy T; Satoskar AA
Lupus; 2018 Dec; 27(14):2236-2244. PubMed ID: 30403144
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
4. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Domingues V; Chock EY; Dufrost V; Risse J; Seshan SV; Barbhaiya M; Sartelet H; Erkan D; Wahl D; Zuily S
Autoimmun Rev; 2022 Oct; 21(10):103158. PubMed ID: 35907609
[TBL] [Abstract][Full Text] [Related]
6. Catastrophic antiphospholipid syndromes in systemic lupus erythematosus.
Stratta P; Canavese C; Ferrero S; Grill A; Salomone M; Schinco PC; Fusaro E; Montaruli B; Santi S; Piccoli G
Ren Fail; 1999 Jan; 21(1):49-61. PubMed ID: 10048117
[TBL] [Abstract][Full Text] [Related]
7. Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients.
Jordan N; Chaib A; Sangle S; Tungekar F; Sabharwal T; Abbs I; Khamashta M; D'Cruz D
Arthritis Care Res (Hoboken); 2014 May; 66(5):725-31. PubMed ID: 24127353
[TBL] [Abstract][Full Text] [Related]
8. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Hughson MD; Nadasdy T; McCarty GA; Sholer C; Min KW; Silva F
Am J Kidney Dis; 1992 Aug; 20(2):150-8. PubMed ID: 1496968
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
10. The estimated prevalence of antiphospholipid antibodies and criteria-antiphospholipid syndrome in subjects with renal thrombotic microangiopathy.
Aluf O; Parente S; Radin M; Campa L; Gazzola V; Olugbogi A; Tesio N; Ugo H; Zanetti E; Zevallos C; Versino E; Lembo D; Roccatello D; Sciascia S
Lupus; 2024 Jan; 33(1):75-82. PubMed ID: 38116607
[TBL] [Abstract][Full Text] [Related]
11. Histological features of antiphospholipid nephropathy in patients with Systemic Lupus Erythematosus.
Naseeb F; Arfaj AA; Hamdani A; Kfoury H; Parvez K; Mogairen SA
J Coll Physicians Surg Pak; 2015 May; 25(5):332-6. PubMed ID: 26008657
[TBL] [Abstract][Full Text] [Related]
12. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus.
Campos LM; Kiss MH; D'Amico EA; Silva CA
Lupus; 2003; 12(11):820-6. PubMed ID: 14667097
[TBL] [Abstract][Full Text] [Related]
14. Renal involvement in antiphospholipid syndrome.
de Azevedo FVA; Maia DG; de Carvalho JF; Rodrigues CEM
Rheumatol Int; 2018 Oct; 38(10):1777-1789. PubMed ID: 29730854
[TBL] [Abstract][Full Text] [Related]
15. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
Mustonen P; Lehtonen KV; Javela K; Puurunen M
Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
[TBL] [Abstract][Full Text] [Related]
16. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.
Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF
Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581
[TBL] [Abstract][Full Text] [Related]
17. Association of antiphospholipid antibodies with clinical activity and renal pathological activity in patients with lupus nephritis.
Zhang J; Zhang J; Zhou Q; Lu G; You X
Lupus; 2021 Jun; 30(7):1140-1145. PubMed ID: 33832360
[TBL] [Abstract][Full Text] [Related]
18. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems].
Zdrojewski Z
Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350
[TBL] [Abstract][Full Text] [Related]
19. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies.
Naarendorp M; Spiera H
J Rheumatol; 1998 Mar; 25(3):589-92. PubMed ID: 9517786
[TBL] [Abstract][Full Text] [Related]
20. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
